enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
2 hedge funds and large institutions have $1K invested in enVVeno Medical Corporation Warrants in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
80% less capital invested
Capital invested by funds: $5K → $1K (-$4K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.21K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFSG
1
Newbridge Financial Services Group
Boca Raton,
Florida
| $1K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$4.21K | -12,847 | -99% |
|
|
PAG
3
Private Advisor Group
Morristown,
New Jersey
| – | -$2K | -10,000 | Closed |
|
NVNOW Hedge Fund Activity: Q3 2021 in Review
2 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q3 2021, worth a combined $1K — down 80% from $5K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NVNOW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $4.21K.
- 2 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q3 2021, down from 3 in Q2 2021.
- Funds reported $1K of enVVeno Medical Corporation Warrants stock for Q3 2021, down 80% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q3 2021 and 1 closed out, a net change of -1 holder.
- The largest enVVeno Medical Corporation Warrants seller in Q3 2021 was UBS Group, an estimated $4.21K sold.
Based on aggregated 13F filings for Q3 2021.